EUROPEAN NEWS IN BRIEF - Irish A&E efficiency scheme a fillip for endoscopy, pathology, imaging:
This article was originally published in Clinica
Executive Summary
Twenty-four Irish hospitals are to share over Euro10m ($13.8m) to invest in A&E service improvements, notably in the areas of endoscopy, pathology and imaging. The funding is being made available under the "100+ Scheme", designed to reward well-performing departments with the creation of consultant posts in priority areas. The first 60 appointments - in emergency medicine, radiology, general medicine, general surgery and geriatric medicine - "will help improve direct GP access to diagnostics and speed up the availability of diagnostic results", according to the Health Service Executive. The projects feature direct access on the part of general practitioners to endoscopy, "real time reporting on X-rays" and faster pathology processing. A further 40 new consultant posts are due to be announced in October.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.